AKT1 and psoriasis: In conclusion, our findings reveal that PCs excellently work in inhibiting the over-proliferation of TNF-α-induced psoriasis-like cells and attenuating inflammatory and OS damage, the underlying mechanism of PCs against psoriasis mainly involving the inhibition of PI3K/AKT and the activation of HO-1.